Controversy: PPARγ a target for treatment of colorectal cancer

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 283, Issue 2 46-2, 2002, Pages

  Gupta, Rajnish A ^a   DuBois, Raymond N ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Intestinal epithelial cell differentiation; Nuclear hormone receptor

Indexed keywords

MUTANT PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; CELL RECEPTOR; LIGAND; TRANSCRIPTION FACTOR;

CANCER GRAFT; CELL PROLIFERATION; COLORECTAL CANCER; GASTROINTESTINAL POLYPOSIS; GENE MUTATION; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; NUDE MOUSE; PRECANCER; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; XENOGRAFT; ANIMAL; COLORECTAL TUMOR; DISEASE MODEL; DRUG POTENTIATION; METABOLISM;

ANIMALS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; LIGANDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0036077277     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00486.2001     Document Type: Review

References (27)

1. PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
2. PPARγ is required for placental, cardiac, and adipose tissue development
3. Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells
4. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer
5. Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas
6. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma
7. The organization, promoter analysis, and expression of the human PPARgamma gene
8. Target genes of peroxisome proliferator-activated receptor {γ} in colorectal cancer cells
9. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma
10. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APC -/+ mice
11. Peroxisome proliferator-activated receptor γ is induced during differentiation of colon epithelium cells
12. Terminal differentiation of human breast cancer through PPARγ
13. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer
14. APC mutations occur early during colorectal tumorigenesis
15. Transcriptional regulation of adipogenesis
16. Activators of the nuclear receptor PPARγ enhance colon polyp formation
17. Differentiation and reversal of malignant changes in colon cancer through PPARγ
18. Loss-of-function mutations in PPAR gamma associated with human colon cancer
19. Rapid colorectal adenoma formation initiated by conditional targeting of the APC gene
20. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
21. A new ligand for the peroxisome proliferator-activated receptor-γ (PPAR-γ), GW7845, inhibits rat mammary carcinogenesis
22. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane
23. Activation of PPARγ inhibits cell growth and induces apoptosis in human gastric cancer cells
24. Ligands for peroxisome proliferator-activated receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats
25. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor
26. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice
27. The PPARs: From orphan receptors to drug discovery